203 related articles for article (PubMed ID: 38720882)
1. Integrated enhancer regulatory network by enhancer-promoter looping in gastric cancer.
Zhu T; Okabe A; Usui G; Fujiki R; Komiyama D; Huang KK; Seki M; Fukuyo M; Abe H; Ning M; Okada T; Minami M; Matsumoto M; Fan Q; Rahmutulla B; Hoshii T; Tan P; Morikawa T; Ushiku T; Kaneda A
NAR Cancer; 2024 Jun; 6(2):zcae020. PubMed ID: 38720882
[TBL] [Abstract][Full Text] [Related]
2. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
Wu Y; Jia Z; Ge X; Wu Q
Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
[TBL] [Abstract][Full Text] [Related]
4. An enhancer RNA recruits KMT2A to regulate transcription of Myb.
Kim J; Diaz LF; Miller MJ; Leadem B; Krivega I; Dean A
Cell Rep; 2024 Jun; 43(7):114378. PubMed ID: 38889007
[TBL] [Abstract][Full Text] [Related]
5. An enhancer RNA recruits MLL1 to regulate transcription of
Kim J; Diaz LF; Miller MJ; Leadem B; Krivega I; Dean A
bioRxiv; 2023 Oct; ():. PubMed ID: 37808852
[TBL] [Abstract][Full Text] [Related]
6. Enhancer RNA Transcription Is Essential for a Novel CSF1 Enhancer in Triple-Negative Breast Cancer.
Lewis MW; Wisniewska K; King CM; Li S; Coffey A; Kelly MR; Regner MJ; Franco HL
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406623
[TBL] [Abstract][Full Text] [Related]
7. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
8. Three murine leukemia virus integration regions within 100 kilobases upstream of c-myb are proximal to the 5' regulatory region of the gene through DNA looping.
Zhang J; Markus J; Bies J; Paul T; Wolff L
J Virol; 2012 Oct; 86(19):10524-32. PubMed ID: 22811527
[TBL] [Abstract][Full Text] [Related]
9. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer.
Li W; Okabe A; Usui G; Fukuyo M; Matsusaka K; Rahmutulla B; Mano Y; Hoshii T; Funata S; Hiura N; Fukayama M; Tan P; Ushiku T; Kaneda A
Cancer Sci; 2021 Aug; 112(8):3349-3362. PubMed ID: 34014591
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3.
Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A
Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176
[TBL] [Abstract][Full Text] [Related]
11. Aberrant activation of CYR61 enhancers in colorectal cancer development.
Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
[TBL] [Abstract][Full Text] [Related]
12. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.
Drier Y; Cotton MJ; Williamson KE; Gillespie SM; Ryan RJ; Kluk MJ; Carey CD; Rodig SJ; Sholl LM; Afrogheh AH; Faquin WC; Queimado L; Qi J; Wick MJ; El-Naggar AK; Bradner JE; Moskaluk CA; Aster JC; Knoechel B; Bernstein BE
Nat Genet; 2016 Mar; 48(3):265-72. PubMed ID: 26829750
[TBL] [Abstract][Full Text] [Related]
13.
Yao X; Tan J; Lim KJ; Koh J; Ooi WF; Li Z; Huang D; Xing M; Chan YS; Qu JZ; Tay ST; Wijaya G; Lam YN; Hong JH; Lee-Lim AP; Guan P; Ng MSW; He CZ; Lin JS; Nandi T; Qamra A; Xu C; Myint SS; Davies JOJ; Goh JY; Loh G; Tan BC; Rozen SG; Yu Q; Tan IBH; Cheng CWS; Li S; Chang KTE; Tan PH; Silver DL; Lezhava A; Steger G; Hughes JR; Teh BT; Tan P
Cancer Discov; 2017 Nov; 7(11):1284-1305. PubMed ID: 28893800
[TBL] [Abstract][Full Text] [Related]
14. v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter.
Chayka O; Kintscher J; Braas D; Klempnauer KH
Mol Cell Biol; 2005 Jan; 25(1):499-511. PubMed ID: 15601869
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional interactions between enhancers and promoters during intestinal differentiation depend upon HNF4.
Chen L; Cao W; Aita R; Aldea D; Flores J; Gao N; Bonder EM; Ellison CE; Verzi MP
Cell Rep; 2021 Jan; 34(4):108679. PubMed ID: 33503426
[TBL] [Abstract][Full Text] [Related]
16. Enhancer dependence of cell-type-specific gene expression increases with developmental age.
Cai W; Huang J; Zhu Q; Li BE; Seruggia D; Zhou P; Nguyen M; Fujiwara Y; Xie H; Yang Z; Hong D; Ren P; Xu J; Pu WT; Yuan GC; Orkin SH
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21450-21458. PubMed ID: 32817427
[TBL] [Abstract][Full Text] [Related]
17. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.
Ho SWT; Sheng T; Xing M; Ooi WF; Xu C; Sundar R; Huang KK; Li Z; Kumar V; Ramnarayanan K; Zhu F; Srivastava S; Isa ZFBA; Anene-Nzelu CG; Razavi-Mohseni M; Shigaki D; Ma H; Tan ALK; Ong X; Lee MH; Tay ST; Guo YA; Huang W; Li S; Beer MA; Foo RSY; Teh M; Skanderup AJ; Teh BT; Tan P
Gut; 2023 Feb; 72(2):226-241. PubMed ID: 35817555
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles for c-Myb and core binding factor/polyoma enhancer-binding protein 2 in the assembly and function of a multiprotein complex on the TCR delta enhancer in vivo.
Hernández-Munain C; Krangel MS
J Immunol; 2002 Oct; 169(8):4362-9. PubMed ID: 12370369
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the murine Ddelta2 promoter by upstream stimulatory factor 1, Runx1, and c-Myb.
Carabana J; Ortigoza E; Krangel MS
J Immunol; 2005 Apr; 174(7):4144-52. PubMed ID: 15778374
[TBL] [Abstract][Full Text] [Related]
20. Evaluating Enhancer Function and Transcription.
Field A; Adelman K
Annu Rev Biochem; 2020 Jun; 89():213-234. PubMed ID: 32197056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
